Project Grant HT94252311059
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$921K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
This $693,642 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of Virginia to enhance vaccine-induced tumor-infiltrating lymphocytes (VITILS) in melanoma. The 3-year research project aims to develop innovative approaches to boost the effectiveness of cancer immunotherapies by improving the ability of T cells to infiltrate and attack melanoma tumors. Key deliverables will include...
The U.S. Department of Defense's Defense Health Agency awarded a $638,260 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Rector & Visitors of the University of Virginia (UVA) with a period of performance from September 1, 2025 to August 31, 2027. The grant supports advanced biomedical research aimed at "Linking Genetic, Metabolic, and Microenvironmental Predictors of Melanoma Metastatic Colonization." As a prominent academic...
The University of Virginia (UVA) received a $847,875 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective September 1, 2025 through August 31, 2028, will support research targeting Schwann cell-tumor microenvironment interactions in neurofibroma development. The federal grant funding will enable UVA to conduct advanced biomedical research aimed at transforming healthcare for military service members,...
This federal Project Grant award of $1,592,860.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The award was granted to the Rector & Visitors of the University of Virginia, a prominent academic research institution, to conduct ultrasensitive proteomics research for type 1 diabetes prediction and treatment efficacy...
The University of Virginia was awarded a $2,728,777 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on May 1, 2025, will support advanced biomedical research on "Neuroactive Steroid Biosynthesis and Dynamic GABAA Receptor Reconfiguration in Postpartum Depression" over a performance period ending on April 30, 2029. This research aims to transform healthcare for military service...
This $646,252 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research to uncover cell intrinsic and extrinsic factors governing melanoma dormancy at single-cell resolution. The primary awardee, Trustees of Boston University, will conduct this advanced biomedical research. The University of Virginia will provide academic and technical resources, including experiments generating and validating...
The University of Virginia will receive $748,422 under a three-year Project Grant award from the Department of the Army Medical Command. The award is funded through the Military Medical Research and Development program (CFDA 12.420). The University will quantify the relationship between brain biomechanics and head exposures relevant to warfighters. Insights gained from this research aim to guide the development of future injury prevention technologies. Specifically, the University seeks to...
The Department of Defense's Defense Health Agency awarded a $558,832 Project Grant to Tufts University School of Medicine under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2024. This grant will support research focused on "Targeting Differentiation Epitope in CD11b of Tumor-Associated Inflammatory Monocytes: A Novel Adjuvant Dendritic Cell Therapy Approach for Mucosal Melanoma." The research aims to develop an innovative dendritic cell-based...
The U.S. Defense Health Agency (DHA) awarded a $5,540,949 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Rector & Visitors of the University of Virginia (UVA) to conduct focused ultrasound interventions research for the noninvasive treatment of primary and metastatic breast cancers. The 4-year grant, awarded on September 30, 2025, supports UVA's work to develop advanced focused ultrasound technologies for precise, non-surgical cancer therapies....
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $523,266 project grant to the University of California Irvine. The 3-year grant, awarded on Sep 15, 2023, will support intravital imaging research on melanoma tumors to improve understanding of the mechanisms of action and patient surveillance for checkpoint blockade immunotherapy. The project aims to leverage UC Irvine's research capabilities and specialized facilities in biomedical...